Form 8-K - Current report:
SEC Accession No. 0000950170-23-033261
Filing Date
2023-07-18
Accepted
2023-07-18 08:01:13
Documents
14
Period of Report
2023-07-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20230717.htm   iXBRL 8-K 58420
2 EX-99.1 prok-ex99_1.htm EX-99.1 24058
3 GRAPHIC img22993735_0.jpg GRAPHIC 85539
  Complete submission text file 0000950170-23-033261.txt   313374

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prok-20230717.xsd EX-101.SCH 2472
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prok-20230717_lab.xml EX-101.LAB 13904
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prok-20230717_pre.xml EX-101.PRE 10232
8 EXTRACTED XBRL INSTANCE DOCUMENT prok-20230717_htm.xml XML 4900
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 231093031
SIC: 2836 Biological Products, (No Diagnostic Substances)